Biotechnology Stocks I Performance Guide: Xenon Pharmaceuticals Inc. (XENE)
XENE has no dividends.
Table and Chart of XENE Performance
See what a $1,000 investment in XENE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| XENE Returns | |
|---|---|
| Start Date | Dec-31-2014 |
| Start Price | $19.75 |
| End Date | May-17-2024 |
| End Price | $39.80 |
| # Prices | 114 |
| Min Date | Nov-30-2017 |
| Min Price | $2.45 |
| Max Date | Feb-29-2024 |
| Max Price | $47.20 |
| Total Return | 101.52% |
| Annualized Return | 7.65% |
| Current Value of $1,000 Purchase | $2,015 |
| Number Returns | 6,441 |
| Average Return | 183.47% |
| Number Profitable Returns | 5,149 |
| Percent Profitable Returns | 79.94% |
| Number Unprofitable Returns | 1,292 |
| Percent Unprofitable Returns | 20.06% |
| Profitable to Unprofitable Returns Ratio | 3.99 |
| XENE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $3,003,662,000 |
| Beta | 1.189 | Price to Sales | 181.44 |
| Earnings per Share | $-2.7200 |
| PE Ratio | None |
| PE to Growth Ratio | -0.06 |
| Price to Book | 3.355 |
| PRICE DATA | |
| 52 Week High | $50.99 |
| 52 Week Low | $27.98 |
| Analyst Target Price | $57.9 |
| 50-Day Moving Average | $42.24 |
| 200-Day Moving Average | $40.04 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -23.9% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
XENE Compare Returns with S&P 500
XENE Trendline Chart
XENE Moving Average Chart
XENE Stock Return Map - See Patterns of Gains and Losses
XENE Stock Returns/Purchase Dates